Correlation Between Enterprise and Phoenix Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enterprise and Phoenix Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enterprise and Phoenix Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enterprise 40 Technology and Phoenix Biotech Acquisition, you can compare the effects of market volatilities on Enterprise and Phoenix Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enterprise with a short position of Phoenix Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enterprise and Phoenix Biotech.

Diversification Opportunities for Enterprise and Phoenix Biotech

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Enterprise and Phoenix is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Enterprise 40 Technology and Phoenix Biotech Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phoenix Biotech Acqu and Enterprise is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enterprise 40 Technology are associated (or correlated) with Phoenix Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phoenix Biotech Acqu has no effect on the direction of Enterprise i.e., Enterprise and Phoenix Biotech go up and down completely randomly.

Pair Corralation between Enterprise and Phoenix Biotech

Assuming the 90 days horizon Enterprise 40 Technology is expected to generate 0.43 times more return on investment than Phoenix Biotech. However, Enterprise 40 Technology is 2.35 times less risky than Phoenix Biotech. It trades about 0.36 of its potential returns per unit of risk. Phoenix Biotech Acquisition is currently generating about 0.13 per unit of risk. If you would invest  1,067  in Enterprise 40 Technology on September 12, 2024 and sell it today you would earn a total of  6.00  from holding Enterprise 40 Technology or generate 0.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy88.24%
ValuesDaily Returns

Enterprise 40 Technology  vs.  Phoenix Biotech Acquisition

 Performance 
       Timeline  
Enterprise 40 Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enterprise 40 Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Enterprise is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Phoenix Biotech Acqu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Phoenix Biotech Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Phoenix Biotech is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Enterprise and Phoenix Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enterprise and Phoenix Biotech

The main advantage of trading using opposite Enterprise and Phoenix Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enterprise position performs unexpectedly, Phoenix Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phoenix Biotech will offset losses from the drop in Phoenix Biotech's long position.
The idea behind Enterprise 40 Technology and Phoenix Biotech Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency